National Health Investors, Inc. (NYSE:NHI) Q3 2021 Earnings Conference Call November 8, 2021 5:00 PM ET Company Participants Eric Mendelsohn ??? President and CEO Dana Hambly ??? Vice President, Investor Relations Kevin Pascoe ??? Chief Investment Officer John Spaid ??? Executive Vice President and Chief Financial Officer David Travis ??? Chief Accounting Officer Conference Call Participants Jordan Sadler ??? KeyBanc Capital Markets Juan Sanabria ??? BMO Rich Anderson ??? SMBC Daniel Bernstein ??? Capital O ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) Maryland 62-1470956 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 222 Robert Rose Drive Murfreesboro Tennessee 37129 (Address of principal executive offices) (Zip Code) (615) 890-9100 (Registrant's telephone number, including area code) Securities ...

National Health Investors, Inc. (NYSE:NHI) Q2 2021 Earnings Conference Call August 10, 2021 12:00 PM ET Company Participants Dana Hambly - Director, IR Eric Mendelsohn - President, CEO & Director John Spaid - EVP, Finance & CFO Kevin Pascoe - CIO Conference Call Participants Jordan Sadler - KeyBanc Capital Markets Juan Sanabria - BMO Rich Anderson - SMBC Connor Siversky - Berenberg Daniel Bernstein - Capital One Securities Operator Greetings, and welcome to the National Health Investors Second Quarter 2021 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) Maryland 62-1470956 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 222 Robert Rose Drive Murfreesboro Tennessee 37129 (Address of principal executive offices) (Zip Code) (615) 890-9100 (Registrant's telephone number, including area code) Securities ...

National Health Investors, Inc. (NYSE:NHI) Q1 2021 Earnings Conference Call May 11, 2021 12:00 PM ET Company Participants Dana Hambly - Director of Investor Relations Eric Mendelsohn - President & Chief Executive Officer John Spaid - Executive Vice President & Chief Financial Officer Kevin Pascoe - Chief Investment Officer Conference Call Participants Jordan Sadler - KeyBanc Capital Markets Todd Stender - Wells Fargo John Kim - BMO Capital Markets Omotayo Okusanya - Mizuho Daniel Bernstein - Capital One Ri ...

Q1 2021 NATIONAL HEALTH INVESTORS Q1 2021 SUPPLEMENTAL TABLE OF CONTENTS 1 Q1 2021 National Health Investors | --- | --- | |-------------------------------------|-------| | COMPANY | | | COMPANY INFORMATION & LEADERSHIP | 02 | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | PORTFOLIO SUMMARY | 04 | | OPERATING PARTNERS | 05 | | EBITDARM LEASE COVERAGE | 06 | | PURCHASE OPTIONS & LEASE MATURITIES | 07 | | INVESTMENTS | | | INVESTMENT RATIONALE | 08 | | RECENT INVESTMENTS | 09 | | CAPITALIZATION | | | CAPITALIZ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | | 62-1470956 | | --- | --- | --- | | (State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) | | 222 Robert Rose Drive | | | | Murfreesboro | Tennessee | 37129 | | (Address of principal executive offices) | | (Zip Code) | (615) 890-9100 (Re ...

National Health Investors, Inc. (NYSE:NHI) Q4 2020 Earnings Conference Call February 23, 2021 12:00 PM ET Company Participants Dana Hambly - Director, IR Eric Mendelsohn - President & CEO John Spaid - EVP & CFO Kevin Pascoe - CIO David Travis - CAO Conference Call Participants Daniel Bernstein - Capital One Securities Rich Anderson - SMBC Jordan Sadler - KeyBanc Capital Markets Omotayo Okusanya - Mizuho Securities John Kim - BMO Capital Markets Connor Siversky - Berenberg Operator Greetings, and welcome to ...

Q4 2020 NATIONAL HEALTH INVESTORS Q4 2020 SUPPLEMENTAL TABLE OF CONTENTS 1 Q4 2020 National Health Investors | --- | --- | |-------------------------------------|-------| | COMPANY | | | COMPANY INFORMATION & LEADERSHIP | 02 | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | PORTFOLIO SUMMARY | 04 | | OPERATING PARTNERS | 05 | | EBITDARM LEASE COVERAGE | 06 | | PURCHASE OPTIONS & LEASE MATURITIES | 07 | | INVESTMENTS | | | INVESTMENT RATIONALE | 08 | | RECENT INVESTMENTS | 09 | | CAPITALIZATION | | | CAPITALIZ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number 001-10822 National Health Investors Inc Indicate by check mark if the registrant is not required to file reports ...